|
[X] |
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 28, 2020
|
|
[ ] |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from ________________ to _______________
|
Connecticut
|
06-0330020
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
incorporation or organization)
|
Identification No.)
|
112 Bridge Street, Naugatuck, Connecticut
|
06770
|
(Address of principal executive offices)
|
(Zip Code)
|
(203)-729-2255
|
Registrant’s telephone number
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, No Par Value
|
EML
|
NASDAQ Global Market
|
Large accelerated filer [ ]
|
Accelerated filer [X]
|
Non-accelerated filer [ ]
|
Smaller reporting company [X]
|
Emerging growth company [ ]
|
Page
|
||
PART I
|
||
3.
|
||
17.
|
||
25.
|
||
25.
|
||
PART II
|
||
26.
|
||
26.
|
||
28.
|
||
28.
|
||
28.
|
||
28.
|
||
28.
|
||
29.
|
Three Months Ended
|
||||||||
March 28, 2020
|
March 30, 2019
|
|||||||
Net sales
|
$
|
65,325,616
|
$
|
60,883,148
|
||||
Cost of products sold
|
(50,663,943
|
)
|
(47,074,105
|
)
|
||||
Gross margin
|
14,661,673
|
13,809,043
|
||||||
Product development expense
|
(775,444
|
)
|
(2,239,776
|
)
|
||||
Selling and administrative expense
|
(10,024,958
|
)
|
(8,398,265
|
)
|
||||
Restructuring costs
|
—
|
(836,694
|
)
|
|||||
Operating profit
|
3,861,271
|
2,334,308
|
||||||
Interest expense
|
(827,664
|
)
|
(292,540
|
)
|
||||
Other income
|
744,793
|
13,925
|
||||||
Income before income taxes
|
3,778,400
|
2,055,693
|
||||||
Income taxes
|
882,583
|
484,733
|
||||||
Net income
|
$
|
2,895,817
|
$
|
1,570,960
|
||||
Earnings per share:
|
||||||||
Basic
|
$
|
.46
|
$
|
.25
|
||||
Diluted
|
$
|
.46
|
$
|
.25
|
||||
Cash dividends per share:
|
$
|
.11
|
$
|
.11
|
Three Months Ended
|
||||||||
March 28, 2020
|
March 30, 2019
|
|||||||
Net income
|
$
|
2,895,817
|
$
|
1,570,960
|
||||
Other comprehensive income (loss):
|
||||||||
Change in foreign currency translation
|
(1,304,447
|
)
|
412,624
|
|||||
Change in pension and postretirement benefit costs, net of tax expense of: 2020 – $81,143 and 2019 - $70,938
|
260,295
|
222,681
|
||||||
Change in fair value of marketable securities, net of tax benefit of: 2020 - $2,897 and 2019 - $3,471
|
8,878
|
(10,639
|
)
|
|||||
Change in fair value of interest rate swap and marketable securities, net of tax benefit of: 2020 – $535,029 and 2019 – $24,619
|
(1,697,793
|
)
|
(77,961
|
)
|
||||
Total other comprehensive income (loss)
|
(2,733,067
|
)
|
546,705
|
|||||
Comprehensive income
|
$
|
162,750
|
$
|
2,117,665
|
||||
ASSETS
|
March 28, 2020
|
December 28, 2019
|
||||||
(unaudited)
|
||||||||
Current Assets
|
||||||||
Cash and cash equivalents
|
$
|
16,508,881
|
$
|
17,996,505
|
||||
Marketable securities
|
23,154
|
34,305
|
||||||
Accounts receivable, less allowances: 2020 - $699,000;2019 - $556,000
|
39,873,177
|
37,941,900
|
||||||
Inventories
|
55,274,876
|
54,599,266
|
||||||
Prepaid expenses and other assets
|
3,955,872
|
4,343,507
|
||||||
Total Current Assets
|
115,635,960
|
114,915,483
|
||||||
Property, Plant and Equipment
|
88,409,321
|
88,336,243
|
||||||
Accumulated depreciation
|
(46,482,754
|
)
|
(46,313,630
|
)
|
||||
41,926,567
|
42,022,613
|
|||||||
Goodwill
|
79,418,533
|
79,518,012
|
||||||
Trademarks
|
5,404,283
|
5,404,283
|
||||||
Patents and other intangibles net of accumulated amortization
|
25,699,680
|
26,460,110
|
||||||
Right of Use Assets
|
11,852,653
|
12,342,475
|
||||||
122,375,149
|
123,724,880
|
|||||||
TOTAL ASSETS
|
$
|
279,937,676
|
$
|
280,662,976
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
March 28, 2020
|
December 28, 2019
|
||||||
(unaudited)
|
||||||||
Current Liabilities
|
||||||||
Accounts payable
|
$
|
22,629,076
|
$
|
19,960,507
|
||||
Accrued compensation
|
2,216,765
|
3,815,186
|
||||||
Other accrued expenses
|
3,797,178
|
2,967,961
|
||||||
Current portion of long-term debt
|
5,187,689
|
5,187,689
|
||||||
Total Current Liabilities
|
33,830,708
|
31,931,343
|
||||||
Deferred income taxes
|
5,270,465
|
5,270,465
|
||||||
Other long-term liabilities
|
2,465,260
|
2,465,261
|
||||||
Lease liability
|
11,852,653
|
12,342,475
|
||||||
Long-term debt, less current portion
|
92,356,121
|
93,577,544
|
||||||
Accrued postretirement benefits
|
1,001,509
|
1,007,146
|
||||||
Accrued pension cost
|
28,052,482
|
28,631,485
|
||||||
Shareholders’ Equity
|
||||||||
Voting Preferred Stock, no par value:
|
||||||||
Authorized and unissued: 1,000,000 shares
|
||||||||
Nonvoting Preferred Stock, no par value:
|
||||||||
Authorized and unissued: 1,000,000 shares
|
||||||||
Common Stock, no par value, Authorized: 50,000,000 shares
|
30,890,108
|
30,651,815
|
||||||
Issued: 8,980,460 shares in 2020 and 8,975,434 shares in 2019
|
||||||||
Outstanding: 6,230,731 shares in 2020 and 6,240,705 shares in 2019
|
||||||||
Treasury Stock: 2,749,729 shares in 2020 and 2,734,729 shares in 2019
|
(20,537,962
|
)
|
(20,169,098
|
)
|
||||
Retained earnings
|
122,723,970
|
120,189,111
|
||||||
Accumulated other comprehensive income (loss):
|
||||||||
Foreign currency translation
|
(3,342,399
|
)
|
(2,037,952
|
)
|
||||
Unrealized gain on marketable securities, net of tax
|
8,878
|
—
|
||||||
Unrealized gain (loss) on interest rate swap, net of tax
|
(1,530,775
|
)
|
167,018
|
|||||
Unrecognized net pension and postretirement benefit costs, net of tax
|
(23,103,342
|
)
|
(23,363,637
|
)
|
||||
Accumulated other comprehensive loss
|
(27,967,638
|
)
|
(25,234,571
|
)
|
||||
Total Shareholders’ Equity
|
105,108,478
|
105,437,257
|
||||||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
|
$
|
279,937,676
|
$
|
280,662,976
|
Three Months Ended
|
||||||||
March 28, 2020
|
March 30, 2019
|
|||||||
Operating Activities
|
||||||||
Net income
|
$
|
2,895,817
|
$
|
1,570,960
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation and amortization
|
2,055,782
|
1,438,799
|
||||||
Unrecognized pension and postretirement benefits
|
(678,305
|
)
|
207,816
|
|||||
(Gain)/loss on sale of equipment and other assets
|
(437,446
|
)
|
671,138
|
|||||
Provision for doubtful accounts
|
156,286
|
25,711
|
||||||
Stock compensation expense
|
238,293
|
104,992
|
||||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable
|
(2,273,864
|
)
|
(2,123,227
|
)
|
||||
Inventories
|
(994,546
|
)
|
1,313,875
|
|||||
Prepaid expenses and other
|
341,582
|
(81,231
|
)
|
|||||
Other assets
|
(415,415
|
)
|
101,919
|
|||||
Accounts payable
|
2,766,829
|
(27,186
|
)
|
|||||
Accrued compensation
|
(1,585,976
|
)
|
(1,724,968
|
)
|
||||
Other accrued expenses
|
(564,572
|
)
|
11,718
|
|||||
Net cash provided by operating activities
|
1,504,465
|
1,490,316
|
||||||
Investing Activities
|
||||||||
Marketable securities
|
11,151
|
(91,400
|
)
|
|||||
Capitalized software
|
—
|
(104,484
|
)
|
|||||
Proceeds from sale of equipment
|
445,212
|
—
|
||||||
Purchases of property, plant and equipment
|
(828,115
|
)
|
(743,622
|
)
|
||||
Net cash used in investing activities
|
(371,752
|
)
|
(939,506
|
)
|
||||
Financing Activities
|
||||||||
Principal payments on long-term debt
|
(1,221,423
|
)
|
(387,500
|
)
|
||||
Purchase common stock for treasury
|
(368,864
|
)
|
—
|
|||||
Dividends paid
|
(686,614
|
)
|
(686,740
|
)
|
||||
Net cash used in financing activities
|
(2,276,901
|
)
|
(1,074,240
|
)
|
||||
Effect of exchange rate changes on cash
|
(343,436
|
)
|
144,954
|
|||||
Net change in cash and cash equivalents
|
(1,487,624
|
)
|
(378,476
|
)
|
||||
Cash and cash equivalents at beginning of period
|
17,996,505
|
13,925,765
|
||||||
Cash and cash equivalents at end of period
|
$
|
16,508,881
|
$
|
13,547,289
|
||||
Non-cash investing and financing activities |
(489,822
|
) | ||||||
Right of use asset |
489,822
|
|||||||
Lease liability |
Three Months Ended
|
||||||||
March 28, 2020
|
March 30, 2019
|
|||||||
Basic:
|
||||||||
Weighted average shares outstanding
|
6,237,921
|
6,231,713
|
||||||
Diluted:
|
||||||||
Weighted average shares outstanding
|
6,237,921
|
6,231,713
|
||||||
Dilutive stock appreciation rights
|
3,131
|
33,116
|
||||||
Denominator for diluted earnings per share
|
6,241,052
|
6,264,829
|
March 28, 2020
|
December 28, 2019
|
|||||||
Raw material and component parts
|
$
|
17,438,617
|
$
|
17,225,469
|
||||
Work in process
|
11,145,881
|
11,009,648
|
||||||
Finished goods
|
26,690,378
|
26,364,149
|
||||||
Total inventories
|
$
|
55,274,876
|
$
|
54,599,266
|
Three Months Ended
March 28, 2020
|
Year Ended
December 28, 2019
|
|||||||||||||||
Units
|
Weighted - Average Exercise Price
|
Units
|
Weighted - Average Exercise Price
|
|||||||||||||
Outstanding at beginning of period
|
276,000
|
$
|
22.30
|
189,167
|
$
|
21.46
|
||||||||||
Issued
|
--
|
--
|
96,000
|
23.65
|
||||||||||||
Exercised
|
--
|
--
|
(1,667
|
)
|
19.10
|
|||||||||||
Forfeited
|
(6,999
|
)
|
19.10
|
(7,500
|
)
|
21.20
|
||||||||||
Outstanding at end of period
|
269,001
|
22.39
|
276,000
|
22.30
|
||||||||||||
|
SARs Outstanding and Exercisable
|
||||||||||||||||||||||||||
Range of Exercise Prices
|
Outstanding as of
March 28, 2020
|
Weighted- Average Remaining Contractual Life
|
Weighted- Average Exercise Price
|
Exercisable as of
March 28, 2020
|
Weighted- Average Remaining Contractual Life
|
Weighted- Average Exercise Price
|
||||||||||||||||||||
$
|
19.10-26.30
|
269,001
|
3.0
|
$
|
22.39
|
50,001
|
2.0
|
19.10
|
Three Months Ended
March 28, 2020
|
Year Ended
December 28, 2019
|
|||||||||||||||
Shares
|
Weighted - Average Exercise Price
|
Shares
|
Weighted - Average Exercise Price
|
|||||||||||||
Outstanding at beginning of period
|
25,000
|
$
|
—
|
25,000
|
$
|
—
|
||||||||||
Issued
|
—
|
—
|
—
|
—
|
||||||||||||
Forfeited
|
—
|
—
|
—
|
—
|
||||||||||||
Outstanding at end of period
|
25,000
|
—
|
25,000
|
—
|
Stock Grants Outstanding and Exercisable
|
||||||||||||||||||||||||||
Range of Exercise Prices
|
Outstanding as of
March 28, 2020
|
Weighted- Average Remaining Contractual Life
|
Weighted- Average Exercise Price
|
Exercisable as of
March 28, 2020
|
Weighted- Average Remaining Contractual Life
|
Weighted- Average Exercise Price
|
||||||||||||||||||||
$
|
0.00
|
25,000
|
2.0
|
—
|
—
|
—
|
—
|
Period
|
Total
Number of
Shares
Purchased
|
Average
Price Paid
Per Share
|
Total Number of
Shares
Purchased As
Part of Publicly
Announced Plans
or Programs
|
Maximum Number
of Shares That May
Yet be Purchased
Under the Plans or
Programs
|
||||||||||||
Balance as of December 28, 2019
|
40,000
|
$
|
26.58
|
40,000
|
160,000
|
|||||||||||
December 29, 2019 – March 28, 2020
|
15,000
|
24.59
|
15,000
|
145,000
|
||||||||||||
Balance as of March 28, 2020
|
55,000
|
$
|
26.04
|
55,000
|
145,000
|
•
|
Net operating losses arising in 2018, 2019, and 2020 taxable years may be carried back to each of the preceding five years, which may result in refunds of prior period corporate income tax. The Company had
taxable income in 2018 and 2019, thus we would only benefit from this item of CARES Act relief to the extent we incur a tax net operating loss in 2020 that can be carried back. As of March 28, 2020, a tax net operating loss is not expected
for taxable year 2020. In addition, this item of CARES Act relief increased the positive evidence supporting utilization of our gross deferred tax assets due to available income in carryback years; this did not change our overall assessment
as we do not have a valuation allowance recorded against our deferred tax assets.
|
•
|
Furthermore, for taxable years beginning before 2021, net operating loss carryforwards and carrybacks to that year may offset 100% of taxable income in the year. Previously, net operating losses generated
through 2017 could offset 100% of taxable income, while losses generated after 2017 could only offset 80% of taxable income. The Company had taxable income in 2018 and 2019 and would carry back a loss generated in 2020 if applicable, leaving
minimal opportunity to benefit from this item of CARES Act relief.
|
•
|
For taxable years beginning in 2019 and 2020, the interest deduction limitation is increased from 30% to 50% of “adjusted taxable income” (taxable income without interest, tax depreciation and tax amortization)
plus interest income. Furthermore, the Company may choose to use the 2019 adjusted taxable income (instead of 2020) in determining the 2020 interest expense limitation. The Company was not subject to an interest limitation in 2019 and
therefore expects to use the 2019 adjusted taxable income if needed to avoid or reduce an interest expense limitation in 2020.
|
•
|
A technical correction to the Tax Cuts and Jobs Act permits bonus depreciation and a 15-year straight-line recovery period on qualified improvement property placed in service after December 31, 2017. Prior to
this technical correction, such property placed in service after 2017 was subject to the 39-year straight-line recovery period and was ineligible for bonus depreciation. To the extent the Company has eligible improvements in 2020, the Company
can claim bonus depreciation which would reduce taxes payable and increase the deferred tax liability for fixed assets.
|
•
|
Other CARES Act corporate income tax provisions will not significantly impact the company, including alternative minimum tax refunds and increases in the charitable contributions deduction limitation.
|
Pension Benefits
|
Postretirement Benefits
|
|||||||||||||||
Three Months Ended
|
Three Months Ended
|
|||||||||||||||
March 28,
2020
|
March 30,
2019
|
March 28,
2020
|
March 30,
2019
|
|||||||||||||
Service cost
|
$
|
266,436
|
$
|
263,852
|
$
|
10,855
|
$
|
8,216
|
||||||||
Interest cost
|
714,143
|
879,080
|
11,667
|
20,346
|
||||||||||||
Expected return on plan assets
|
(1,365,261
|
)
|
(1,190,330
|
)
|
(5,589
|
)
|
(14,481
|
)
|
||||||||
Amortization of prior service cost
|
24,845
|
24,845
|
(2,063
|
)
|
(1,268
|
)
|
||||||||||
Amortization of the net loss
|
325,034
|
290,549
|
(6,377
|
)
|
(20,507
|
)
|
||||||||||
Net periodic benefit cost (benefit)
|
$
|
(34,803
|
)
|
$
|
267,996
|
$
|
8,493
|
$
|
(7,694
|
)
|
For the Three Months Ended
|
||||||||
March 28, 2020
|
March 30, 2019
|
|||||||
Regular matching contribution
|
$
|
204,992
|
$
|
156,267
|
||||
Transitional credit contribution
|
82,127
|
103,524
|
||||||
Non-discretionary contribution
|
567,657
|
587,041
|
||||||
Total contributions made for the period
|
$
|
854,776
|
$
|
846,832
|
Three Months Ended
|
||||||||
March 28, 2020
|
March 30, 2019
|
|||||||
Revenues:
|
||||||||
Sales to unaffiliated customers:
|
||||||||
Industrial Hardware
|
$
|
47,236,605
|
$
|
38,403,343
|
||||
Security Products
|
12,384,484
|
14,683,004
|
||||||
Metal Products
|
5,704,527
|
7,796,801
|
||||||
$
|
65,325,616
|
$
|
60,883,148
|
|||||
Income before income taxes:
|
||||||||
Industrial Hardware
|
$
|
3,458,893
|
$
|
1,268,140
|
||||
Security Products
|
817,401
|
972,887
|
||||||
Metal Products
|
(415,023
|
)
|
93,281
|
|||||
Operating Profit
|
3,861,271
|
2,334,308
|
||||||
Interest expense
|
(827,664
|
)
|
(292,540
|
)
|
||||
Other income
|
744,793
|
13,925
|
||||||
$
|
3,778,400
|
$
|
2,055,693
|
Three Months Ended March 28, 2020
|
||||||||||||||||
Industrial
|
Security
|
Metal
|
||||||||||||||
Hardware
|
Products
|
Products
|
Total
|
|||||||||||||
Net sales
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
||||||||
Cost of products sold
|
77.4
|
%
|
68.9
|
%
|
97.6
|
%
|
77.6
|
%
|
||||||||
Gross margin
|
22.6
|
%
|
31.1
|
%
|
2.4
|
%
|
22.4
|
%
|
||||||||
Product development expense
|
0.2
|
%
|
5.5
|
%
|
—
|
1.2
|
%
|
|||||||||
Selling and administrative expense
|
15.1
|
%
|
19.0
|
%
|
9.7
|
%
|
15.3
|
%
|
||||||||
Restructuring cost
|
—
|
—
|
—
|
—
|
||||||||||||
Operating profit
|
7.3
|
%
|
6.6
|
%
|
-7.3
|
%
|
5.9
|
%
|
||||||||
Three Months Ended March 30, 2019
|
||||||||||||||||
Industrial
|
Security
|
Metal
|
||||||||||||||
Hardware
|
Products
|
Products
|
Total
|
|||||||||||||
Net sales
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
100.0
|
%
|
||||||||
Cost of products sold
|
76.9
|
%
|
70.9
|
%
|
91.3
|
%
|
78.7
|
%
|
||||||||
Gross margin
|
23.1
|
%
|
29.1
|
%
|
8.7
|
%
|
22.7
|
%
|
||||||||
Product development expense
|
4.2
|
%
|
4.3
|
%
|
—
|
3.7
|
%
|
|||||||||
Selling and administrative expense
|
13.4
|
%
|
18.1
|
%
|
7.5
|
%
|
13.8
|
%
|
||||||||
Restructuring cost
|
2.2
|
%
|
1.4
|
%
|
||||||||||||
Operating profit
|
3.3
|
%
|
6.7
|
%
|
1.2
|
%
|
3.8
|
%
|
Industrial
|
Security
|
Metal
|
||||||||||||||
Hardware
|
Products
|
Products
|
Total
|
|||||||||||||
Net sales
|
$
|
8,833
|
$
|
(2,299
|
)
|
$
|
(2,092
|
)
|
$
|
4,442
|
||||||
Volume
|
20.9
|
%
|
-17.0
|
%
|
-30.2
|
%
|
5.2
|
%
|
||||||||
Prices
|
1.1
|
%
|
1.0
|
%
|
0.7
|
%
|
1.0
|
%
|
||||||||
New products
|
1.0
|
%
|
0.4
|
%
|
2.6
|
%
|
1.1
|
%
|
||||||||
23.0
|
%
|
-15.6
|
%
|
-26.9
|
%
|
7.3
|
%
|
|||||||||
Operating profit
|
$
|
2,191
|
$
|
(156
|
)
|
$
|
(508
|
)
|
$
|
1,527
|
||||||
172.7
|
%
|
-16.0
|
%
|
-544.9
|
%
|
65.4
|
%
|
First
Quarter
2020
|
First
Quarter
2019
|
Year
End
2019
|
||||||||||
Current ratio
|
3.4
|
3.6
|
3.6
|
|||||||||
Average days’ sales in accounts receivable
|
57
|
49
|
51
|
|||||||||
Inventory turnover
|
3.6
|
3.7
|
4.2
|
|||||||||
Total debt to shareholders’ equity
|
92.8
|
%
|
28.8
|
%
|
93.7
|
%
|
First
|
First
|
Year
|
||||||||||
Quarter
|
Quarter
|
End
|
||||||||||
2020
|
2019
|
2019
|
||||||||||
Cash and cash equivalents
|
||||||||||||
- Held in the United States
|
$
|
9.6
|
$
|
4.1
|
$
|
9.0
|
||||||
- Held by a foreign subsidiary
|
6.9
|
9.5
|
9.0
|
|||||||||
16.5
|
13.6
|
18.0
|
||||||||||
Working capital
|
81.8
|
72.8
|
83.0
|
|||||||||
Net cash provided by operating activities
|
1.5
|
1.5
|
23.0
|
|||||||||
Change in working capital impact on net cash
(used) in operating activities
|
(2.7
|
)
|
(2.5
|
)
|
(0.3
|
)
|
||||||
Net cash (used) in investing activities
|
(0.4
|
)
|
(0.9
|
)
|
(85.8
|
)
|
||||||
Net cash (used) in financing activities
|
(2.3
|
)
|
(1.1
|
)
|
(67.0
|
)
|
•
|
The Company has operations in Shanghai and Dongguan, China that have been adversely affected by the impact of COVID-19. The virus interfered with the ability of Company employees and
suppliers to conduct business. We source approximately 15% of our products and components from China. As a result of government mandated shutdowns at the Company’s and its suppliers’ factories in China, many of the products ordered have
been delayed by approximately 4 to 6 weeks, which has resulted and will continue to result in corresponding delays in delivery of the Company’s products to its customers. These delays have had and are likely to continue to have an adverse
impact on our business, operations, fulfillment of production requirements and operating results,
|
•
|
On March 11, 2020, the World Health Organization declared the rapidly spreading COVID-19 outbreak to be a global pandemic, and shortly thereafter government authorities in the United States
began closing non-essential business. The majority of the Company’s businesses are considered essential and have remained open but are operating at reduced levels. This reduction in operations has exacerbated delays in delivery of customer
orders and, to the extent we continue to operate at reduced levels, is likely to cause further delays. Any sustained reduction in operations could impair the Company’s ability to meet production requirements in a timely manner or at all.
These effects have had and are likely to continue to have an adverse impact on the Company’s business, financial condition and operating results.
|
•
|
Many of the Company’s customers in both automotive and non-automotive industries experienced varying degrees of shutdowns beginning in the last week of March 2020, with some of these customers tentatively
expected to begin reopening as soon as May 4, 2020. These temporary shutdowns have had and, for so long as they remain in place, are likely to continue to have, an adverse impact on demand for our products. A sustained decrease in demand
would negatively impact our business, financial condition and operating results. In addition, the COVID-19 pandemic has had and may continue to have an adverse impact on the operations, financial results and finances of many of our customers,
which has impacted and could continue to impact customer payment cycles and payments due from customers.
|
•
|
The broader economic impact of the COVID-19 may result in unfavorable operating earnings and cash flow generation in the months to follow. Current global economic conditions are highly
volatile due to the COVID-19 pandemic, resulting in economic slowdowns that [have caused and] [may]/[are likely to] [continue to] cause contractions in some or all of the markets we serve, which [has led to]/[may lead to]/[is likely to lead
to] decreased demand for the Company’s products, which in turn is expected to negatively impact the Company’s financial condition and operating results. Other macroeconomic factors also remain dynamic, and any causes of market size
contraction, including economic uncertainty related to the United Kingdom's exit from the European Union, and overall economic slowdowns, could reduce the Company’s sales or erode operating margin, in either case reducing earnings. In
addition, volatile global economic conditions may cause foreign exchange rate fluctuations, which could result in increases or decreases in earnings and may adversely affect the value of the Company’s assets outside the United States.
Increased pricing in response to fluctuations in foreign currency exchange rates may offset portions of the currency impacts but could also have a negative impact on demand for the Company’s products, which would affect sales and profits.
Exchange rate fluctuations could also increase pricing pressure and impair the ability of the Company’s products to compete with products imported from regions with favorable exchange rates.
|
•
|
Shutdowns or other restrictions imposed to slow the spread of COVID-19 have impacted and may continue to impact the prices and availability of certain of the raw materials used in the
production of the Company’s products, which could impair the Company’s ability to procure the required raw materials for its operations or increase the cost of manufacturing its products. If the price of raw materials increases, the Company
may be unable to pass these increases on to its customers and could experience reductions to its profit margins. Also, any decrease in the availability of raw materials could impair the Company’s ability to meet production requirements in a
timely manner or at all.
|
•
|
The Company’s management has been focused on mitigating the impact of the COVID-19 pandemic on our employees and operations, which has required and will continue to require a substantial
investment of time and resources. This has resulted and can be expected to continue to result in a diversion of management attention and resources away from strategic, initiatives, new business opportunities, potential acquisitions, and the
overall profitability of our business, and the Company cannot predict how long this may continue.
|
•
|
The economic downturn could also result in the carrying value of goodwill or other intangible assets exceeding their fair value, which could require the Company to recognize asset
impairment.
|
•
|
To the extent the Company draws under the revolving portion of the Credit Agreement, debt of the Company would increase. Such an increase in indebtedness could adversely affect the
Company’s financial results or ability to incur additional debt and could negatively impact credit ratings. The continuing impact of the COVID-19 pandemic could also negatively impact the Company’s compliance with the financial covenants
under the Credit Agreement or the interest rate of borrowings under the Credit Agreement. In addition, as a result of the risks described above, the Company may in the future be required to raise additional debt or equity financing, and the
availability, terms and cost of such financing would depend on, among other things, global economic conditions, conditions in the global financing markets, trading prices of the Company’s common stock, the credit ratings of the Company, and
the outlook for the industries in which the Company operates, all of which could be negatively impacted by the COVID-19 pandemic. There can be no assurance that such financing would be available on acceptable terms, in sufficient quantities,
or at all.
|
THE EASTERN COMPANY
|
|
(Registrant)
|
|
DATE: May 6, 2020
|
/s/August M. Vlak
|
August M. Vlak
President and Chief Executive Officer
|
|
DATE: May 6, 2020
|
/s/John L. Sullivan III
|
John L. Sullivan III
Vice President and Chief Financial Officer
|
|
FIRST: |
That the name of the corporation is The Eastern Company.
|
SECOND: |
That said corporation is to be located in the Town of Naugatuck, in the State of Connecticut.
|
THIRD: |
That the nature of the business to be transacted and the purposes to be promoted or carried out by the said corporation are as follows:
|
FOURTH: |
The authorized capital stock of the corporation shall consist of fifty million (50,000,000) shares of common stock, having no par value, one million (1,000,000)
shares of a single class of voting preferred stock having no par value, and one million (1,000,000) shares of a single class of non-voting preferred stock having no par value.
|
FIFTH: |
The terms, limitations and relative rights and preferences of each class of shares and series thereof are as follows:
|
|
(a) |
Subject to the rights of the preferred stock, dividends may be paid upon the common stock as and when declared by the Board of Directors out of funds legally
available for payment of dividends. In the event of any liquidation, dissolution or winding-up of the corporation, whether voluntary or involuntary, subject to the rights of the preferred stock, the remainder of the assets of the
corporation shall be distributed pro rata to the holders of the common stock. Each outstanding share of common stock shall be entitled to one vote on each matter submitted to a vote at all meetings of shareholders.
|
|
(b) |
Shares of the class of voting preferred stock may be divided into and issued in series. Shares of the class of voting preferred stock, or any series thereof, may be
convertible into the same or a different number of authorized shares of common stock or of non-voting preferred stock or any combination thereof. The Board of Directors is authorized to fix and determine the terms, limitations and relative
rights and preferences, including conversion rights, if any, or the class of voting preferred stock and to establish series within such class and to fix and determine the variations as among series. Each outstanding share of voting
preferred stock shall be entitled to one vote on each matter submitted to a vote at all meetings of shareholders.
|
|
(c) |
Shares of the class of non-voting preferred stock may be divided into and issued in series. Shares of the class of non-voting preferred stock, or any series thereof,
may be convertible into the same or a different number of authorized shares of common stock or of voting preferred stock or any combination thereof. The Board of Directors is authorized to fix and determine the terms, limitations and
relative rights and preferences, including conversion rights, if any, of the class of non-voting preferred stock and to establish series within such class and to fix and determine the variations as among series. The shares of said class of
non-voting preferred stock shall not be entitled to vote except when required under the General Statutes of the State of Connecticut.
|
SIXTH: |
That the amount of capital stock with which this corporation shall commence business is Ten Million Dollars ($10,000,000)
|
SEVENTH: |
That the duration of said corporation is unlimited.
|
EIGHTH: |
No stockholder of the corporation shall by reason of his holding shares of capital stock of the corporation have any pre-emptive or preferential rights to purchase or
subscribe to any shares of any class of stock of the corporation, now or hereafter to be authorized, or to any notes, debentures, bonds or other securities (whether or not convertible into or carrying options or warrants to purchase shares
of any class of capital stock) now or hereafter to be authorized, excepting only such pre-emptive or preferential rights, warrants or options as the Board of Directors in its discretion may grant from time to time.
|
NINTH: |
Each member of the Board of Directors of the corporation shall be elected by the stockholders at the annual meeting of the stockholders, and shall serve for a term of
one year. Except in a contested election, directors shall be elected by a majority of the votes cast by the shares entitled to vote in the election of directors at the annual meeting of the stockholders at which a quorum is present (that
is, if the votes cast for a nominee’s election as a director exceed the votes cast against such nominee’s election as a director). In a contested election, directors shall be elected by a plurality of the votes cast at such annual
meeting. An election shall be considered to be contested if, as of the record date for such annual meeting, there are more nominees for election to the Board of Directors than there are positions on the Board of Directors to be filled by
election at the annual meeting. Any director elected to fill a vacancy shall hold office until the next annual meeting of stockholders.
|
TENTH: |
To the extent permitted by Section 33-290(c)(2) of the Connecticut General Statutes and as the same may be amended or supplemented from time to time, the personal
liability of the directors to the corporation or its shareholders for monetary damages for breach of duty as a director shall be limited to an amount equal to the compensation received by the director for serving the corporation during
the year of the violation.
|
•
|
the holders of 80% of the voting power of the outstanding shares of the Company’s voting stock; and
|
•
|
the holders of 2/3 of the voting power of the outstanding shares of the Company’s voting stock, excluding the voting stock held by the interested
shareholder;
|
1.
|
I have reviewed this report on Form 10-Q of The Eastern Company;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control
over financial reporting.
|
1.
|
I have reviewed this report on Form 10-Q of The Eastern Company;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control
over financial reporting.
|
1.
|
I have reviewed this report on Form 10-Q of The Eastern Company;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control
over financial reporting.
|
1.
|
I have reviewed this report on Form 10-Q of The Eastern Company;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent
fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control
over financial reporting.
|